Hydroxymethylglutaryl-CoA Reductase Inhibitors
"Hydroxymethylglutaryl-CoA Reductase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis.
MeSH Number(s)
D27.505.519.186.071.202.370
D27.505.519.389.370
D27.505.954.557.500.202.370
Concept/Terms
Hydroxymethylglutaryl-CoA Reductase Inhibitors- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hydroxymethylglutaryl CoA Reductase Inhibitors
- Inhibitors, Hydroxymethylglutaryl-CoA Reductase
- Reductase Inhibitors, Hydroxymethylglutaryl-CoA
- Statins, HMG-CoA
- HMG-CoA Statins
- Statins, HMG CoA
- Inhibitors, Hydroxymethylglutaryl-CoA
- Hydroxymethylglutaryl-CoA Inhibitors
- Inhibitors, Hydroxymethylglutaryl CoA
- Inhibitors, Hydroxymethylglutaryl-Coenzyme A
- Hydroxymethylglutaryl-Coenzyme A Inhibitors
- Inhibitors, Hydroxymethylglutaryl Coenzyme A
- HMG-CoA Reductase Inhibitors
- HMG CoA Reductase Inhibitors
- Reductase Inhibitors, HMG-CoA
- Inhibitors, HMG-CoA Reductase
- Inhibitors, HMG CoA Reductase
Below are MeSH descriptors whose meaning is more general than "Hydroxymethylglutaryl-CoA Reductase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Hydroxymethylglutaryl-CoA Reductase Inhibitors".
This graph shows the total number of publications written about "Hydroxymethylglutaryl-CoA Reductase Inhibitors" by people in Harvard Catalyst Profiles by year, and whether "Hydroxymethylglutaryl-CoA Reductase Inhibitors" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 3 | 4 |
1995 | 0 | 1 | 1 |
1997 | 3 | 0 | 3 |
1998 | 7 | 1 | 8 |
1999 | 3 | 1 | 4 |
2000 | 13 | 6 | 19 |
2001 | 17 | 4 | 21 |
2002 | 29 | 3 | 32 |
2003 | 27 | 12 | 39 |
2004 | 31 | 6 | 37 |
2005 | 45 | 3 | 48 |
2006 | 45 | 23 | 68 |
2007 | 49 | 17 | 66 |
2008 | 38 | 24 | 62 |
2009 | 51 | 14 | 65 |
2010 | 51 | 18 | 69 |
2011 | 67 | 26 | 93 |
2012 | 66 | 20 | 86 |
2013 | 63 | 22 | 85 |
2014 | 77 | 20 | 97 |
2015 | 97 | 27 | 124 |
2016 | 60 | 35 | 95 |
2017 | 82 | 28 | 110 |
2018 | 74 | 26 | 100 |
2019 | 69 | 35 | 104 |
2020 | 73 | 36 | 109 |
2021 | 68 | 14 | 82 |
2022 | 97 | 4 | 101 |
2023 | 69 | 4 | 73 |
2024 | 7 | 0 | 7 |
Below are the most recent publications written about "Hydroxymethylglutaryl-CoA Reductase Inhibitors" by people in Profiles.
-
Bringing Evidence to the Nursing Home: Do Statins Have a Role for Prevention in Patients With and Without Dementia? Neurology. 2024 Mar 26; 102(6):e209262.
-
N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events. Circ Res. 2024 Mar; 134(5):e3-e14.
-
SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis. Carcinogenesis. 2024 Feb 12; 45(1-2):35-44.
-
Icosapent ethyl for hypertriglyceridaemia and atherosclerosis: greater RESPECT for increased therapeutic use. Eur Heart J. 2024 Feb 07; 45(6):439-442.
-
Optimizing LDL-cholesterol management in ACS patients: Breaking inertia and implementing intensified therapies. Int J Cardiol. 2024 Apr 01; 400:131803.
-
Trends of Lipid Concentrations, Awareness, Evaluation, and Treatment in Severe Dyslipidemia in US Adults. Mayo Clin Proc. 2024 Feb; 99(2):271-282.
-
Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells via Inhibition of RAD51 Expression. Anticancer Res. 2024 Jan; 44(1):93-98.
-
Effect of bisphosphonates and statins on the in vitro radiosensitivity of breast cancer cell lines. Pharmacol Rep. 2024 Feb; 76(1):171-184.
-
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease. Eur J Prev Cardiol. 2023 12 21; 30(18):1950-1962.
-
New statin use, mortality, and first cardiovascular events in older US Veterans by frailty status. J Am Geriatr Soc. 2024 Feb; 72(2):410-422.